Andrew J Carroll
Overview
Explore the profile of Andrew J Carroll including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
167
Citations
9785
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gupta S, Rau R, Kairalla J, Rabin K, Wang C, Angiolillo A, et al.
N Engl J Med
. 2024 Dec;
392(9):875-891.
PMID: 39651791
Background: B-cell acute lymphoblastic leukemia (B-cell ALL) is the most common childhood cancer. Despite a high overall cure rate, relapsed B-cell ALL remains a leading cause of cancer-related death among...
2.
Gao M, Chen Y, Lertwilaiwittaya P, Hurst A, Al-Beshri A, Carroll A, et al.
Am J Med Genet A
. 2024 Dec;
197(4):e63951.
PMID: 39622782
Aplastic anemia, characterized by pancytopenia and hypoplastic bone marrow, is associated with various acquired cytogenetic abnormalities, including trisomy 8, in 4%-15% of patients. Constitutional mosaic trisomy 8 notably increases the...
3.
Drucker M, Lee D, Zhang X, Kain B, Bowman M, Nicolet D, et al.
bioRxiv
. 2024 Nov;
PMID: 39605444
Acute myeloid leukemia (AML) is a multi-clonal disease, existing as a milieu of clones with unique but related genotypes as initiating clones acquire subsequent mutations. However, bulk sequencing cannot fully...
4.
Stiff A, Fornerod M, Kain B, Nicolet D, Kelly B, Miller K, et al.
Nat Genet
. 2024 Oct;
56(11):2434-2446.
PMID: 39367245
Genomic profiles and prognostic biomarkers in patients with acute myeloid leukemia (AML) from ancestry-diverse populations are underexplored. We analyzed the exomes and transcriptomes of 100 patients with AML with genomically...
5.
Fobare S, Sharpe C, Quinn K, Bryant K, Miles L, Bowman R, et al.
bioRxiv
. 2024 Sep;
PMID: 39345464
Mutations in protein tyrosine phosphatase non-receptor type 11 ( ) have been considered late acquired mutations in acute myeloid leukemia (AML) development. To interrogate the ontogeny of mutations, we utilized...
6.
Ozga M, Nicolet D, Mrozek K, Walker C, Blachly J, Kohlschmidt J, et al.
Am J Hematol
. 2024 Sep;
99(11):2236-2240.
PMID: 39283025
No abstract available.
7.
Rheingold S, Bhojwani D, Ji L, Xu X, Devidas M, Kairalla J, et al.
Leukemia
. 2024 Sep;
38(11):2382-2394.
PMID: 39261601
Limited prognostic factors have been associated with overall survival (OS) post-relapse in childhood Acute Lymphoblastic Leukemia (ALL). Patients enrolled on 12 Children's Oncology Group frontline ALL trials (1996-2014) were analyzed...
8.
Guest E, Kairalla J, Devidas M, Hibbitts E, Carroll A, Heerema N, et al.
Haematologica
. 2024 Jun;
109(12):3918-3927.
PMID: 38867582
Infants less than 1 year old diagnosed with KMT2A-rearranged (KMT2A-r) acute lymphoblastic leukemia (ALL) are at high risk of failure to achieve remission, relapse, and death due to leukemia, despite...
9.
Lee J, Tran Q, McGee R, Perrino M, Upadhyaya S, Hanzlik E, et al.
Neuropathol Appl Neurobiol
. 2024 Mar;
50(2):e12971.
PMID: 38488196
No abstract available.
10.
Ozga M, Nicolet D, Mrozek K, Yilmaz A, Kohlschmidt J, Larkin K, et al.
Leukemia
. 2023 Nov;
38(1):45-57.
PMID: 38017103
Clinical outcome of patients with acute myeloid leukemia (AML) is associated with demographic and genetic features. Although the associations of acquired genetic alterations with patients' sex have been recently analyzed,...